Abstract
Background Understanding the spatiotemporal variation of COVID-19 transmission and its determinants is crucial for gaining deeper insights into the dynamics of disease spread. Regional and temporal differences in demographics, socioeconomic conditions, and environmental factors shaped the trajectory of the COVID-19 pandemic, underscoring the importance of advanced spatio-temporal modelling. This research aims to construct a spatiotemporal model to examine the relationship between age groups, poverty, population density, precipitation, and COVID-19 risk, as well as to pinpoint high-risk areas.
Methods Here we present a spatiotemporal statistical analysis using COVID-19 case data from Malawi recorded from 2 April 2020 to 27 March 2022. Bayesian spatiotemporal models were fitted, with weekly confirmed cases as the response variable and demographic, socioeconomic, and environmental factors as predictors.
Results The findings reveal that spatial and temporal factors, along with age, population density, and poverty, significantly affect observed COVID-19 incidence in Malawi, whereas precipitation does not. The greatest risk was observed during colder months (June–July), December’s festive season, and January. Urban centres and lake-shore districts were disproportionately impacted, with individuals aged 40 − 49 at particularly high risk.
Conclusions These results emphasise the need to prioritise vaccinations for working-age populations in urban and tourist areas during high-risk periods. Moreover, ensuring adherence to public health guidelines and enhancing healthcare services in these districts is critical.
Key Messages
The age group 40–49 faced a significantly higher risk of COVID-19 compared to all other age groups.
COVID-19 risk is generally low across Malawi during the study period, with Blantyre being a notable exception.
Positive associations were identified between COVID-19 risk and factors such as age, poverty levels, and population density.
Both spatial and temporal dynamics were found to have substantial impacts on COVID-19 transmission risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Schlumberger Foundation-Faculty for the Future and the Wellcome Trust.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the National Commission for Science and Technology, Malawi (Approval No: P.02/23/733) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Links to all data used in this study are provided in the manuscript.
